YAZ
LOE ApproachingNDAORALTABLET
Approved
Oct 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
13
Data completeness
3/8 — Basic
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
YAZ is an oral contraceptive tablet containing a progestin and estrogen that prevents ovulation and is approved for contraception and multiple gynecological indications. Beyond contraception, it is indicated for premenstrual dysphoric disorder, dysmenorrhea, acne vulgaris, premenstrual syndrome, hidradenitis suppurativa, and endometriosis. The product represents a multi-indication oral hormonal therapy targeting women's health.
$0.114MPart D
LOE ApproachingStable
With LOE approaching and minimal Part D spending ($114K in 2023), YAZ is in a mature, stable phase with likely declining brand team resources and a shift toward lifecycle management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (13)
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®
Started Feb 2024
32 enrolled
Healthy Subjects
Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea
Started Jun 2017
715 enrolled
Endometriosis and Dysmenorrhea
YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
Started May 2016
1,921 enrolled
Contraception
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
Started Jan 2016
0Dysmenorrhea
Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles
Started Jul 2014
1,500 enrolled
Contraception
Worked on YAZ at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.